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Abstract
Background: Maternal iodine requirements increase during pregnancy to supply thyroid hormones essential for fetal
brain development. Maternal iodine deficiency can lead to hypothyroxinemia, a reduced fetal supply of thyroid hormones
which, in the first trimester, has been linked to an increased risk of autism spectrum disorder (ASD) in the child. No study
to date has explored the direct link between maternal iodine deficiency and diagnosis of ASD in offspring.
Methods: Urinary iodine concentrations (UIC) and iodine/creatinine ratios (I:Cr) were measured in 6955 mothers at 26–28
weeks gestation participating in the Born in Bradford (BiB) cohort. Maternal iodine status was examined in relation to the
probability of a Read (CTV3) code for autism being present in a child’s primary care records through a series of logistic
regression models with restricted cubic splines.
Results: Median (inter-quartile range) UIC was 76 μg/L (46, 120) and I:Cr was 83 μg/g (59, 121) indicating a deficient
population according to WHO guidelines. Ninety two children (1·3%) in our cohort had received a diagnosis of ASD by
the census date. Overall, there was no evidence to support an association between I:Cr or UIC and ASD risk in children
aged 8–12 years (p = 0·3).
Conclusions: There was no evidence of an increased clinical ASD risk in children born to mothers with mild-to-moderate
iodine deficiency at 26 weeks gestation. Alternative functional biomarkers of exposure and a wider range of conditions
may provide further insight.
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Background
Iodine is a trace mineral present in certain foods. As an es-
sential constituent for the synthesis of thyroid hormones,
iodine plays a vital role in supporting the optimal function-
ing of metabolic processes at all stages of life [1]. Thyroid
hormones (TH) are central to many of the fundamental
processes which underlie the development and maturation
of the pre-natal brain; namely facilitating neural migration
and differentiation in the cerebral cortex and hippocampus
[2, 3]. The maximal vulnerability to an imbalance of TH ex-
ists before the onset of thyroid function in the fetus, which
occurs around 16–20weeks of gestation [4]. During this
time, the highly orchestrated chain of neurodevelopmental
events which characterize the early fetal period are exclu-
sively dependent on maternal TH supply.
A woman’s iodine requirements are increased by over
50% during pregnancy [5] in order to support normal
neurological development, and to compensate for
pregnancy-associated increases in renal iodine clearance
[5]. Severe maternal iodine deficiency can lead to a reduced
fetal TH supply [5] (hypothyroxinemia) which, during crit-
ical developmental periods, is thought to impair neuronal
migration and has been linked to long-term suboptimal
child development [1].
The importance of thyroid function for neurodevelop-
ment has been widely recognised for over a century [6], this
is reflected in initiatives such as the World Health
Organization (WHO)‘s salt iodization programme, which is
now standard practice in many parts of the world [7]. The
widespread implementation of such interventions, in con-
junction with improved general nutrition, has given rise to
a diminishing prevalence of iodine deficiency disorders in
Western Europe [1]. Nevertheless, iodine intake remains
potentially inadequate, especially in countries such as the
UK which have not implemented iodization programmes.
Suboptimal gestational iodine intake has been linked with
an increase in Attention Deficit, Hyperactivity Disorder
(ADHD) symptom scores in children [8], poorer child lan-
guage and reading skills [9], as well as a heightened likeli-
hood of the child receiving special education services at age
8 years [9]. Yet few studies have directly investigated the
possible linkage between gestational iodine deficiency and
developmental disorders, such as autism spectrum disorder
(ASD) – a developmental disorder characterised by difficul-
ties with social interaction and communication, and by re-
stricted and repetitive patterns of behaviour [10].
Despite comprehensive genetic studies, the aetiology of
ASD remains largely unknown [11] with a potentially im-
portant role of environmental factors during fetal develop-
ment [12], possibly through interference with neuronal
migration [13]. Severe maternal iodine deficiency causing
transient gestational hypothyroxinemia in rodents has been
shown to induce cortical neuronal migration brain lesions
resembling those-characteristic of autism [14]. Findings
from epidemiologic studies [15, 16] provide observational
evidence to support the notion that early intrauterine ex-
posure to insufficient thyroid hormone levels could be an
important cause of ASD. Severe maternal hypothyroxine-
mia measured during the first trimester of pregnancy was
associated with an increased risk of ASD identified through
record linkage in the United States [15] and abnormal ma-
ternal thyroid functioning in early pregnancy was associated
with ASD in the offspring in The Danish National Birth
Cohort Case-Control Study [16]. However, a large cohort
pooling project has found no associations with maternal
iodine status across early or mid-pregnancy and autistic
traits in children [17].
The uncertainties surrounding the potential implica-
tions of low maternal iodine status for the development
of ASD are of heightened relevance given that insuffi-
cient iodine status has been reported amongst women of
childbearing age and pregnant women in the UK [18,
19] The WHO guidelines from which these reports are
based identify pregnant populations as having insuffi-
cient iodine intake where the median urinary iodine con-
centration (UIC) is less than 150 μg/L. [20] This
threshold however, is based on theoretical assumptions
about metabolic needs, absorption, and excretion [1], as
opposed to observed outcomes and therefore is limited
in its application to pregnant populations. Using linked
datasets, the current study aims to directly address and
explore these issues by investigating the association be-
tween maternal iodine status in mid-pregnancy and an
ASD diagnosis in the child, across a continuous range of
urinary iodine concentrations.
Methods
Study design and participants
This research uses data from the Born in Bradford (BiB)
cohort, which consists of 12,453 women recruited at 26–
28 weeks gestation from 2007 to 2010. All babies born to
participants from the 13,776 pregnancies which occurred
during this time were eligible for inclusion, there were
no exclusion criteria for this sample. Iodine status was
estimated from spot urine samples collected from 6644
women (53%) across 6996 pregnancies (some women
participated during successive pregnancies). A detailed
description of the BiB cohort can be found elsewhere
[21]. In brief, the cohort reflects Bradford’s multi-ethnic
population; with 43% of those with urine samples being
of White British heritage and 43% being of Pakistani
heritage. The cohort consists of over half of all children
born at Bradford Royal Infirmary between 2007 and
2011 and is considered broadly representative of the
wider population [21]. Ethical approval for BiB was
granted by Bradford Research Ethics Committee (Ref
07/H1302/112). All participants provided written in-
formed consent prior to data collection.
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Assessment of urinary iodine and creatinine
Urine samples were provided by participants at routine
antenatal clinics for oral glucose tolerance tests follow-
ing an overnight fast. All available samples were centri-
fuged, divided into aliquots and barcode tagged before
being frozen and stored at − 80 °C at the Bradford Royal
Infirmary until their transfer to the Leeds Institute of
Cardiovascular and Metabolic Medicine, University of
Leeds, UK for iodine and creatinine analysis.
Urinary iodine(127) concentration (μg/L) was measured
using inductively coupled plasma-mass spectrometry
(Thermo iCAP Q, Liverpool, UK). The laboratory is accre-
dited under the US Centers for Disease Control and Pre-
vention (CDC) Ensuring the Quality of Urinary Iodine
Procedures (EQUIP) standardisation programme [22]. A
standard Jaffe reaction-based microplate assay was used
for the evaluation of creatinine concentrations. A series of
five quality control (QC) urines (along with a certified ref-
erence material (CRM) (Seronorm trace elements urine L-
1)) were repeatedly analysed in conjunction with partici-
pant samples in order to validate method accuracy. All
QC and CRM categories remained within expected or cer-
tified ranges and displayed low variability.
For inter-laboratory comparison, a subset of BiB and valid-
ation samples (3·8%, 271 of 6971), were provided at regular
intervals to the MRC Elsie Widdowson Laboratory in Cam-
bridge. UIC measurements were highly correlated across sites
(r = 0·99). Details of the full laboratory analysis and validation
protocols are provided in the supplementary material.
Diagnosis of ASD
The primary outcome measure for this study was the pres-
ence of a Read (CTV3) code for an ASD recorded in a
child’s primary care records. In collaboration with our pri-
mary care electronic health provider across Bradford, link-
age was conducted using a complete deterministic match
on National Health Service (NHS) number, surname, sex
and date of birth (99% of BiB children were matched to
their health record). Read codes are the standard clinical
terminology system used in General Practice in the United
Kingdom. A validated READ code list, based on Clinical
Terms Version 3 [23] (Supplemental Table S1) has been
shown in earlier published work [24] to be reliable and
used with confidence to study ASD. Children were aged
between 8 years 3months and 12 years 6 months at the
point of the primary care data extract (4th October 2019).
Additional details of the data-linkage procedure can be
found in the supplementary material.
Statistical analysis
In order to account for variation in urine dilution during
pregnancy [5], the standardised measure of urinary iodine
to creatinine ratio (I:Cr) (μg/g) was used as the primary
exposure, though all analyses were also conducted using
UIC, including pre-specified sensitivity and subgroup ana-
lyses. To avoid categorising iodine concentrations, re-
stricted cubic splines were fitted with four knots placed at
percentiles 5, 35, 65 and 95 [25] and were used in all logis-
tic regression models.
Multiple imputation by chained equations, based on 100
imputed datasets, was used to correct for the effects of in-
complete covariate information [26] (details in Supplemen-
tal Table S2). Adjustment for confounding was informed by
a directed acyclic graph (Supplemental Fig. S1). All reported
results are from fully adjusted models controlling for ma-
ternal age (at study recruitment), ethnicity, socioeconomic
and education category (see details in Supplemental Table
S3) smoking in pregnancy, alcohol in pregnancy, pre-
pregnancy body mass index (BMI) and parity as potential
confounders. Covariates were omitted, as appropriate, for
modelling different outcomes (see Supplemental Table S4).
Pre-specified sensitivity analyses were performed to assess
the robustness of results which included: (i) excluding ex-
treme iodine concentrations (outside 3 standard deviations
(SD) of the mean on the log scale) (n = 41), (ii) the exclu-
sion of iodine-containing supplement users (n = 1036) and
(iii) excluding women with complications in pregnancy
such as hypertension, gestational diabetes or preeclampsia
(n = 909). Evidence of effect modification by child sex, eth-
nicity (White or Pakistani ethnic background), maternal so-
cioeconomic and education category (‘more deprived and
less educated’ or ‘less deprived and more educated’ (details
in Supplementary Material, Table S3) were formally tested
by including an interaction term in the model. Additional
sensitivity analyses were completed using dietary data avail-
able in a sub-sample of the cohort (see Supplemental Table
S4), for paternal age (years) and for seasonality, respectively,
using pairs of sine and cosine functions which were pre-
pared for each date across the year.
Logistic regression models were implemented using
Stata version 15.1 (StataCorp) and a final parsimonious
model was developed to determine the association be-
tween I:Cr and the probability of having an ASD diagnosis
in the primary care records. The Wald test was used to
assess the overall contribution of iodine status to each
model. A two-tailed p-value < 0·05 was considered statisti-
cally significant and 95% confidence intervals (CIs) were
used for all comparisons.
Figures present adjusted predicted outcomes (continu-
ous variables) or probabilities (binary outcomes), across
the range of iodine concentrations for an “average” par-
ticipant, i.e. primiparous, white European, non-smoker,
who did not report consuming alcohol, were employed
and not materially deprived, of mean age (27·2 years)
and BMI (25·8 kg/m2). The predicted probability of hav-
ing a recorded diagnosis of ASD at the 25th and 75th
percentiles of exposure were derived from these figures
and tabulated (Table S5).
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Results
Participant characteristics
Of 12,453 women with 13,776 pregnancies recruited into
the cohort, 6644 women (53%) provided a total of 6977
urine samples at around 26–28 weeks’ gestation. In total,
6955 samples were successfully analysed for both iodine
and creatinine from 6639 women who had a total of
7013 children. Women who provided urine samples
were broadly similar to those in the cohort that did not
(Supplemental Table S6). The mean age of participants
was 27·2 years (SD 5·6) and mean pre-pregnancy BMI
was 25.9 kg/m2 (SD 5·5) (Table 1). Descriptive maternal
details and ASD diagnosis are presented by category of
maternal urinary I:Cr in Tables 1 and 2, respectively.
The median (inter-quartile range (IQR)) UIC for all
samples was 76 μg/L (45 to 120) with 29% below 50 μg/L
(Table 1), indicating a deficient population according to
WHO guidelines [20]. In White European women, the
median UIC (82 μg/L, IQR 49 to 127) was higher than
women of Pakistani (73 μg/L, IQR 42 to 115) or other
ethnic background (72 μg/L, IQR 42 to 111) (Supple-
mentary Material, Table S7). Median (IQR) I:Cr was
83 μg/g (59 to 121) and when the cohort was divided
into five groups according to I:Cr, women with lower I:
Cr were more likely to be grouped in the lower socio-
economic and education categories (Table 1).
Diagnosis of an ASD
Currently, around 1% of children and adults in the UK have
a recorded diagnosis of ASD [27]. In our cohort, 92 chil-
dren (1·3%) had received a diagnosis of ASD by the census
date. Boys had a higher rate of recorded ASD diagnosis
than girls, with approximately 2·0% of boys having a Read
code indicating a diagnosis of ASD in their primary care re-
cords compared to 0·6% of girls (Supplemental Table S8).
There was no evidence of any association between I:Cr
and the risk of a diagnosis of ASD after adjusting for estab-
lished confounders (poverall 0·3) (Fig. 1). Figures present the
adjusted predicted probability of the diagnosis of an ASD,
across the range of iodine concentrations for an “average”
participant, as previously described. For a mother with typ-
ical characteristics (defined above) the probability of an
ASD diagnosis at the 25th percentile of I:Cr (59 μg/g) was
estimated to be 1·0% (0·3–1·7) and at the 75th percentile of
I:Cr (121 μg/g) was estimated as 1.5% (0·5–2·4), respectively
(difference = 0·5 percentage points (95%CI: − 0·1–1·1, p =
0·1). The trend remained broadly flat across the observed
range of I:Cr values. All results were broadly similar using
UIC (Supplementary Material, Fig. S2).
Subgroup and sensitivity analysis
In subgroup analysis, the association between I:Cr and aut-
ism was similar in boys (p = 0.2) and girls (p = 0.1) (p inter-
action = 0·05). There was no evidence that the association
between I:Cr and the probability of having an ASD diagno-
sis in the primary care records was different according to
ethnic background (poverall = 1.0) or maternal deprivation
(poverall = 0·3). Estimates from a sensitivity analysis using
only women with complete data were not substantively dif-
ferent from primary analyses using imputed data (p = 0.3)
and were also similar after excluding iodine-containing sup-
plement users (p = 0.5) and extreme I:Cr values (p = 0.3)
(see Supplemental Fig. S3 a-d). There was no evidence of
any association in the full sample or of differences between
subgroups, across maternal I:Cr (Supplemental Fig. S3 e-j)
and UIC (Supplement Fig. S4 a-f).
Discussion
The present study found no evidence to support a link
between insufficient iodine status in the second-third
trimester and an increased risk of ASD in the child, in a large
multi-ethnic cohort with mild-to-moderate iodine deficiency,
in a setting where there was no routine dietary fortification
or supplementation. Children born to mothers with lower
iodine status were of no greater probability of having a clin-
ical diagnosis of ASD in their primary care records compared
to those born to mothers with higher iodine status.
We found no evidence to indicate any optimum iodine
status or any threshold associated with a heightened risk of
ASD. However, confidence intervals were wide, especially
at the lower range of exposure reflecting the small propor-
tion of participants with I:Cr measurements at very low
levels. Therefore, we cannot exclude the possibility of iod-
ine deficiency being associated with autism, but the study
was underpowered to detect small differences in risk.
A small number of studies have reported associations be-
tween inadequate thyroid hormone supply during the first
trimester of pregnancy and increased ASD risk in children
[14–16], yet the role of iodine in these associations
remained uncertain. Despite the mechanistic link between
iodine and thyroid hormone synthesis, this is to our know-
ledge only the second prospective study to date to investi-
gate any direct link between maternal iodine status and
ASD [17].
Findings from the present study are consistent with a re-
cent cohort pooling project, combining data from 3 large
population-based cohorts [17], which also found no con-
sistent evidence to suggest that a lower maternal iodine
status (< 150 μg/g) at < 14 weeks nor < 18 weeks gestation
was associated with higher parent-reported autistic trait
score in children. Whilst this study used an objective bio-
marker to measure maternal iodine status, the ascertain-
ment of autistic traits was performed at different ages by
different instruments and evaluators, across the 3 cohorts.
This may have potentially introduced some heterogeneity.
Furthermore, this supporting study [17] lacked medical-
record data to confirm ASD diagnosis. A major strength
of our current study lies in our consistent methodology
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and capture of clinical outcome through data linkage with
primary care records of the cohort children. This reduces
scope for subjectivity in the outcome assessment and thus,
minimises bias from misclassification. The present study
remains unique in the objective measure used to inform
our ASD clinical outcome.
Iodine deficiency remains one of the leading causes of
hypothyroidism, both overt and subclinical [28]. However,
hypothyroidism during pregnancy can also be a secondary
Table 1 Maternal characteristics according to urinary iodine to creatinine ratio
Iodine-to-creatinine ratio (cohort split into thirds)
All participants lower third middle third higher third
I:Cr (μg/g), median (range) 83 59·5 (< 67) 83·1 (67 to 105) 121·9 (> 105)
N 6973 2325 2324 2324
I:Cr (μg/g), geometric mean (95% CI) 86·0 (85·0 to 87·2) 48·6 (48·1 to 49·2) 83·4 (82·9 to 83·8) 154·9 (154·9 to 159·3)
I:Cr (μg/g), median (IQR) 83·1 (59·3 to 121·0) 51·5 (42·8 to 59·5) 83·1 (74·4 to 93·3) 145·7 (121·0 to 185·9)
UIC (μg/L), geometric mean (95% CI) 70·8 (69·6 to 72·1) 45·9 (44·6 to 47·2) 69·9 (68·1 to 71·8) 110·6 (107·7 to 113·7)
UIC (μg/L), median (IQR) 76·3 (44·7 to 120·2) 52·1 (29·0 to 78·1) 77·4 (47·4 to 111·4) 117·8 (72·0 to 178·9)
Age (years), mean (SD) 27·2 (5·6) 26·5 (5·5) 27·3 (5·6) 27·9 (5·6)
BMI (kg/M2), mean (SD) 25·9 (5·5) 26·5 (5·7) 25·9 (5·4) 25·2 (5·1)
Socio-economic status†
Least deprived and most educated 1313 (21) 323 (16) 456 (22) 534 (26)
Employed, not materially deprived 1299 (21) 353 (17) 458 (22) 488 (23)
Employed, no access to money 966 (16) 338 (16) 313 (15) 315 (15)
Receives benefits, not materially deprived 1671 (27) 666 (32) 527 (26) 478 (23)
Most economically deprived 954 (15) 378 (19) 304 (15) 272 (13)
Ethnic background, n (%)
White British & European 3020 (43) 847 (36) 1061 (46) 1112 (48)
Pakistani 2951 (43) 1112 (48) 951 (41) 888 (38)
Other (Black, Indian, mixed, other) 964 (14) 353 (15) 299 (13) 312 (14)
Parity
0 3196 (46) 1015 (44) 1055 (46) 1126 (49)
1 1896 (27) 617 (27) 640 (27) 639 (27)
2 1075 (15) 376 (16) 363 (16) 336 (15)
3+ 806 (12) 317 (14) 266 (11) 223 (10)
Health and lifestyle in pregnancy
Gestational diabetes, n (%) 525 (8) 165 (7) 174 (8) 186 (8)
Pre-pregnancy hypertension, n (%) 50 (1) 21 (1) 17 (1) 12 (1)
Pregnancy-induced hypertension, n (%) 383 (5) 128 (5) 127 (5) 128 (6)
Preeclampsia, n (%) 181 (3) 64 (3) 56 (2) 61 (3)
Drank any alcohol, n (%) 1323 (19) 386 (17) 476 (20) 461 (20)
Smoked, n (%) 1014 (15) 321 (14) 366 (16) 327 (14)
Iodine-containing supplements, n (%) 1036 (15) 134 (6) 279 (12) 623 (27)
Total fish intakea (g/d), mean (SD) 23·8 (29·3) 20·9 (28·3) 25·3 (30·8) 25·3 (28·4)
Eat 5 fruit/vegetables per daya, n (%)
Always 441 (18) 128 (15) 164 (20) 149 (19)
Sometimes 1782 (75) 628 (77) 595 (73) 559 (75)
Never 154 (6) 59 (7) 52 (6) 43 (6)
Abbreviations: BMI Body mass index, CI Confidence intervals, I:Cr Urinary iodine to creatinine ratio, IQR Interquartile range, SD Standard deviation, UIC Urinary
iodine concentration
aData from women who were asked about diet in pregnancy (n = 2202)
†See definitions in Supplemental Table S3
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consequence of a number of conditions such as inflamma-
tory disease and autoimmune disorders [29], not just iod-
ine deficiency. Likewise, thyroid hormones can also be
altered by air pollution, pesticides, and exposure to per-
sistent organic pollutants [30], pollutants which have also
been suggested to increase the risk of ASD in children
[31]. Therefore, when relying on measures such as mater-
nal thyroid parameters and recorded diagnoses of pre and
perinatal overt hypothyroidism [14, 15] it is not possible
to determine whether these observed associations with
ASD are directly related to iodine status or confounded by
other environmental exposures. A key strength of our
study is the use of a valid biomarker of iodine status in
pregnant women (I:Cr) [32] which accounts for urine
dilution variability and, when used in conjunction with
our population approach, permits direct and novel explor-
ation of a spectrum of iodine exposure on clinical ASD
outcome, without needing to rely on intermediate thyroid
hormone measures.
Estimating iodine status from single spot urine sam-
ples may introduce potential exposure measurement
error because of day-to-day variation in iodine intake
and excretion that do not reflect true long-term iodine
status, so attenuating our results. However, intra-
individual variation in urine volume was reduced by cor-
recting for urinary creatinine concentration. In particu-
lar, this has been shown to reduce variation, and provide
stronger correlation with 24 h urines, in same-sex groups
Table 2 Observed number of cases of autism spectrum disorder (ASD) both for the cohort as a whole (n = 92) and according to
maternal iodine-to-creatinine ratio (I:Cr). In addition to the modelled predicted probability of a diagnosis of ASD (95% CIs) at the
25th, 50th and 75th centiles of I:Cr, for ‘average’ participantsa
Iodine-to-creatinine ratio
I:Cr (μg/g), median (range)
(n) Observed cases of autism spectrum
disorder (ASD) (n) (percent)
Probability of a diagnosis of autism
spectrum disorder (percent) (95%CIs)
All participants: 6973 92 (1·3%)
Lower third: 59·5, (0·7 to 67) 2325 28 (1·2%) 1·0 (0·3 to 1·7)
Middle third: 83·1, (67 to 105) 2324 27 (1·2%) 1·1 (0·4 to 1·8)
Higher third: 121·9, (> 105) 2324 37 (1·6%) 1·5 (0·5 to 2·4)
a ‘Average’ participants were specified according to the largest categories or mean cohort values. Predicted estimates represent an average birth, not specified by
child’s sex - related to participants who are primiparous, white ethnic background, ‘Employed and not materially deprived’, did not smoke, drink, were of mean
age and an average BMI
Fig. 1 Estimated risk of an autism spectrum disorder for children (aged 8 to 12 years) of typical mothers, across a range of maternal I:Cr concentrations
(μg/g). Histograms illustrate the distribution of iodine concentrations and although the figures are curtailed at 300 μg/g, the splines (solid line) and
95% CIs (dashed lines) were drawn using data from all participants. Splines were drawn after adjustment for confounders (details in Supplemental
Table S4). CIs are particularly wide for very low values of Urinary Iodine/Creatinine. This reflects the very small numbers of women in our sample with
extremely low intakes of iodine (only 3·7% of participants have an I:Cr < 35 μg/g) and does not rule out the potential for a more visible trend in more
severely deficient populations. The spline position in these figures illustrates the predicted estimate for typical participants (primiparous, white ethnic
background, ‘Employed and not materially deprived’, did not smoke, drink or experience complications in pregnancy, of mean age and average BMI
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of a similar age, such as our cohort of young women
[33, 34]. Furthermore, using 24 h urines may have re-
sulted in lower participation rates, potentially reducing
both power and generalisablity.
Timing of urine samples could potentially account for
differences between studies. Peak neuronal migration oc-
curs in humans between the 12th and 20th weeks of gesta-
tion [35], resulting in the formation of the cortical plate. If
iodine insufficiency during a vulnerable window prior to 26
weeks gestation were to impair neuronal migration and if
this increased risk of ASD by that mechanism [36], then
our findings may not fully reflect this process. However,
some studies have failed to find associations between iodine
and ASD at earlier timepoints [8], whilst others have found
associations between neurodevelopmental outcomes and
iodine measured both prior to conception [37] and at later
time points [17]. It is therefore not known if other vulner-
able periods exist prior to conception or during early life
[37] and other mechanisms could exist including later
neuronal migration [38]. UIC at 26 weeks will correlate
with iodine status at both earlier and later time points, so
our findings remain of relevance, but there is scope for add-
itional investigation relating to timing of exposure.
It is possible that results from our study, or previous
studies, may in part reflect residual confounding not
accounted for in regression models. However, we consid-
ered all established risk factors within our causal frame-
work and adjusted for those identified as confounders.
Other pre-natal factors such as parental psychiatric history
and medication use, especially in relation to maternal
mental health, all have reported affiliations with ASD [31]
and warrant further consideration.
ASD has low prevalence in the community [27], so the
numbers of cases were relatively low. We were therefore un-
able to explore some subgroups of interest. It remains pos-
sible that potential cases have been missed if not diagnosed
by the census date. It is possible that such cases could differ
in presentation or cause from those identified in this current
work. However, the long follow-up to age 12 years and
complete record linkage has likely identified most cases, in-
cluding those where diagnosis has been delayed.
Conclusions
The present study found no evidence to support an associ-
ation between mild-moderate iodine deficiency at the end
of the second trimester and a subsequent clinical diagnosis
of ASD in the offspring by age 12. Low incidence of the
outcome in the study population leads to low power to de-
tect weaker associations. As such, this study does not rule
out the potential for some impact of low maternal iodide
intake on ASD or other outcomes in other populations or
in future studies with 24-h urines collected through preg-
nancy, in particular in trimester 1, which would improve
precision and target potentially earlier critical windows of
exposure.
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